Prelude Therapeutics Incorporated

NASDAQ
PRLD
Stock
Yield per half year: -6.31%
Dividend yield: 0%
Sector: Healthcare

Reporting Prelude Therapeutics Incorporated

Capitalization

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Капитализация, млрд $
0.8971 0.4906 0.2761 0.3276 0.182 0.4979 -22.26
Выручка, млрд $
0.007 0.007 0.0070 0.00
Чистая прибыль, млрд $
-0.0147 -0.027 -0.0551 -0.1108 -0.1073 -0.1218 -0.1272 -0.1272 -0.1044 18.21
EV, млрд $
-0.0156 -0.0186 0.8316 0.5524 0.1896 0.2439 0.1022 0.1022 0.3839 -34.25
EBIT, млрд $
-0.0147 -0.0281 -0.0588 -0.1137 -0.1235 -0.1323 -0.1323 -0.0913 36.32
EBITDA, млрд $
-0.0145 -0.0277 -0.0582 -0.1137 -0.1222 -0.1311 -0.1397 -0.1397 -0.1130 19.14
OIBDA, млрд $
-0.0601 -0.1158 -0.1384 -0.1416 -0.1523 -0.1523 -0.1216 20.44
Баланс стоимость, млрд $
-0.0227 -0.0494 0.2122 0.2859 0.1954 0.2371 0.1315 0.1315 0.2124 -9.13
FCF, млрд $
-0.0135 -0.0264 -0.0468 -0.0859 -0.0867 -0.1106 -0.1037 -0.1037 -0.0867 17.25
Операционный денежный поток, млрд $
-0.013 -0.0257 -0.0462 -0.0835 -0.0837 -0.1071 -0.1029 -0.1029 -0.0847 17.37
Операционная прибыль, млрд $
-0.015 -0.0281 -0.0588 -0.1137 -0.1235 -0.1323 -0.1397 -0.1397 -0.1136 18.90
Операционные расходы, млрд $
0.015 0.0281 0.0588 0.1137 0.1235 0.1323 0.1467 0.1467 0.1150 20.06
CAPEX, млрд $
0.000529 0.00078 0.000621 0.0023 0.003 0.0035 0.000764 0.000764 0.0020 4.23


Balance sheet

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
Наличность, млрд $
0.0156 0.0189 0.2183 0.0318 0.0306 0.0253 0.0125 0.0125 0.0637 -43.56
Short Term Investments $
0.2594 0.1711 0.2076 0.1211 0.1211 0.1898 -17.34
Total Current Assets $
0.0156 0.0202 0.2208 0.2951 0.2044 0.2356 0.1359 0.1359 0.2184 -9.25
Чистые активы, млрд $
0.0156 0.0202 0.2208 0.2951 0.0067 0.1753 0.2044 0.1436 54.06
Активы, млрд $
0.0164 0.0219 0.2236 0.3051 0.2205 0.2777 0.1755 0.1755 0.2405 -4.73
Short Term Debt $
0.000258 0.0017 0.0037 0.0015 0.0027 0.0027 0.0020 59.94
Задолженность, млрд $
0.0391 0.0713 0.0114 0.0192 0.0251 0.0406 0.0441 0.0441 0.0281 31.07
Чистый долг, млрд $
-0.0156 -0.0186 -0.2183 -0.0301 -0.0288 -0.0084 0.0056 0.0056 -0.0560 -148.06
Долг, млрд $
0.000258 67 0.0017 0.0018 0.0169 0.018 0.018 13.41 -80.69
Расходы на обслуживание долга $
0.002 0.0013 0.0068 0.0013 0.0034 50.37
Амортизация, млрд $
0.000149 0.000382 0.000542 0.000915 0.0013 0.0012 0.0012 0.0009 25.73
Себестоимость, млрд $
0.000382 0.000542 0.0022 0.003 0.0012 0.0018 0.0018 0.0017 27.13


Share

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -0.4572 -0.8342 -4.42 -2.41 -2.27 -2.02 -1.68 -1.68 -2.5600 -17.59
Цена акции ао 74.76 71.55 5.53 4.27 1.28 1.04 1.04 16.73 -57.10
Число акций ао, млн 32 32 12 46 47.37 60.36 75.81 75.81 48.31 44.58
FCF/акцию -0.42 -0.8162 -3.75 -1.86 -1.83 -1.83 -1.37 -1.37 -2.1280 -18.24


Efficiency

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 64.69 74.98 -67.7 -44.48 -44.6 -56.33 -69.01 -69.01 17.60 -56.4240 0.38
ROA, % -89.48 -141.24 -44.89 -41.91 -40.84 -48.91 -56.12 -56.12 5.71 -46.5340 4.57
ROIC, % -69.95 -44.54 -38.49 17.65 -57.2450 -20.20
ROS, % 0 0 -1816.76 -1816.76 -1816.76 13.36 -1816.7600 0.00
ROCE, % -105.17 -165 -27.69 -39.78 -62.14 -51.7 -100.62 -100.62 9.73 -56.3860 29.44
Ebit margin, % -1889.67 -1889.67 -1889.6700 0.00
Рентаб EBITDA, % 0 0 0 -1995.91 -1995.91 -1995.91 26.54 -1995.9100 0.00
Чистая рентаб, % 0 0 0 -1816.76 -1816.76 13.36 -1816.7600 0.00
Operation Margin, % 0 -1995.91 -1995.91 -1995.91 16.64 -1995.9100 0.00
Доходность FCF, % -2.54 -4.97 -26.46 -33.75 -16.9300 90.92


Coefficients

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
-32.4 1.3 -3.05 -2.69 0.88 64.96 -9.2100 -46.32
P/BV
4.95 2.04 1.12 1.06 0.7352 0.7352 8.15 1.98 -31.71
P/S
13.81 13.81 7.50 13.81 0.00
P/FCF
-39.41 -20.14 -3.78 -2.1 -1.65 -1.76 -1.76 8.97 -5.8860 -38.58
E/P
-0.0309 -0.0641 -0.3274 -0.3719 -0.6694 -0.6988 -0.6988 0.03 -0.4263 61.25
EV/EBIT
0.6625 -58.87 -5.03 -1.53 -1.84 -1.84 -0.7726 -0.7726 -2.2025 -31.25
EV/EBITDA
1.07 0.6716 -14.28 -4.86 -1.55 -1.86 -0.7315 -0.7315 51.61 -4.6563 -44.81
EV/S
0 14.6 14.6 14.6 7.82 14.60 0.00
EV/FCF
0.7041 -73.92 -6.66 -2.19 -2.21 -0.986 -0.986 -0.986 17.75 -2.6064 -31.75
Debt/EBITDA
-0.0093 -0.0154 -0.015 -0.1288 -0.129 -0.129 -0.129 2.58 -0.0834 52.97
Netdebt/Ebitda
1.05 0.6716 3.75 0.2667 0.2354 0.0641 -0.0397 -0.0397 -0.0397 0.46 0.0974 -168.32
Debt/Ratio
0.0118 0.0057 0.0083 0.0608 0.1027 0.1027 0.1027 0.24 0.0560 78.29
Debt/Equity
-0.0052 0.0061 0.0094 0.0712 0.1371 0.3351 0.3351 1.91 0.1118 122.83
Debt/Net Income
-0.0094 -0.0157 -0.0171 -0.1386 -0.1417 -0.1417 -0.1417 10.75 -0.0910 55.27
PEG
-1.42 -1.42 -1.4200 0.00
Бета
0 -7.84 0.42 2.55 -5.94 -0.5923 -0.5923 -0.19 -2.2805 -40.35
Индекс Альтмана
1.42 -4.45 -4.17 -14.75 21.27 21.27 12.59 -0.1360 71.83


Dividends

IFRS
Reporting Annual
2020 2021 2022 2023 LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 0 0 0 0 1.71
Дивиденды / прибыль, %
0 0 0 0 155.02


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM CAGR 5
Всего задолженность
0.0024 0.0048 0.0114 68.10
Персонал, чел
100 113 122 128 6.37
CAPEX/Выручка, %
10.91 10.91 0.00